Item 7.01. Regulation FD Disclosure.

BeiGene, Ltd. (the "Company") will be meeting with investors at the J.P. Morgan 39th Annual Healthcare Conference during the week of January 10, 2021 in San Francisco (the "J.P. Morgan Conference"). A copy of the Company's presentation to be shared with investors at the J.P. Morgan Conference is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. The presentation shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing or this Current Report.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits.
     Exhibit No.                                           Description

         99.1                 Company Presentation dated January 10, 2021.

         104                  The cover page from this Current Report on Form 8-K, formatted in
                              Inline XBRL.

--------------------------------------------------------------------------------



                                 Exhibit Index

     Exhibit No.                                           Description

        99.1                   Company Presentation dated January     10    , 2021.

         104                 The cover page from this Current Report on Form 8-K, formatted in
                             Inline XBRL.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses